[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Tan et al., 2008 - Google Patents

A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice

Tan et al., 2008

View PDF
Document ID
18345736605940572956
Author
Tan Y
Timakhov R
Rao M
Altomare D
Xu J
Liu Z
Gao Q
Jhanwar S
Di Cristofano A
Wiest D
Knepper J
Testa J
Publication year
Publication venue
Cancer research

External Links

Snippet

The oncogene v-akt was isolated from a retrovirus that induced murine thymic lymphomas. Transgenic mice expressing a constitutively activated form of the cellular homologue Akt2 specifically in immature T cells develop spontaneous thymic lymphomas. We hypothesized …
Continue reading at pdfs.semanticscholar.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Similar Documents

Publication Publication Date Title
Li et al. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1
Dietrich et al. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A‐ARF locus
Amati et al. Myc and the cell cycle
Thébault et al. HBZ interacts with JunD and stimulates its transcriptional activity
Sakamuro et al. The polyproline region of p53 is required to activate apoptosis but not growth arrest
Zhao et al. Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression
Li Survivin study: what is the next wave?
Besson et al. Involvement of p21Waf1/Cip1 in protein kinase C alpha-induced cell cycle progression
Schwaller et al. Transformation of hematopoietic cell lines to growth‐factor independence and induction of a fatal myelo‐and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
Meyyappan et al. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells
Singer et al. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells
Xu et al. Individual CREB‐target genes dictate usage of distinct cAMP‐responsive coactivation mechanisms
Bois et al. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts
Takash et al. SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling
Ohkubo et al. The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation
Tran et al. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains
Carrasco et al. Expression of rel B transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells
Hsieh et al. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27Kip1 and inactivation of cdk2 kinase
Chin et al. The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma
Deveaux et al. p45 NF‐E2 regulates expression of thromboxane synthase in megakaryocytes
Krosl et al. Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells
Kadono et al. Biological implications of somatic DDX41 p. R525H mutation in acute myeloid leukemia
Kaul et al. Direct interaction with and activation of p53 by SMAR1 retards cell‐cycle progression at G2/M phase and delays tumor growth in mice
Liu et al. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins
Tanaka et al. Dual function of histone H3 lysine 36 methyltransferase ASH1 in regulation of Hox gene expression